American International Group’s Caribou Biosciences CRBU Stock Holding History

American International Group’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-40,347	Closed	-$207K	–	630
2024 Q1	$207K	Sell	40,347 -346	-0.9%	-$2.13K	﹤0.01%	2130
2023 Q4	$233K	Buy	40,693 +3,413	+9%	+$16.9K	﹤0.01%	2094
2023 Q3	$178K	Buy	37,280 +9,900	+36%	+$61.4K	﹤0.01%	2190
2023 Q2	$116K	Buy	27,380 +309	+1%	+$1.39K	﹤0.01%	2478
2023 Q1	$144K	Buy	27,071 +540	+2%	+$3.36K	﹤0.01%	2296
2022 Q4	$167K	Sell	26,531 -97	-0.4%	-$863	﹤0.01%	2232
2022 Q3	$281K	Buy	26,628 +1,354	+5%	+$12.6K	﹤0.01%	1946
2022 Q2	$137K	Buy	25,274 +21	+0.1%	+$161	﹤0.01%	2410
2022 Q1	$232K	Buy	25,253 +14,477	+134%	+$153K	﹤0.01%	2152
2021 Q4	$163K	Buy	10,776 +280	+3%	+$5.45K	﹤0.01%	2478
2021 Q3	$251K	Buy	+10,496	New	+$257K	﹤0.01%	2288

Other funds holding CRBU

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

EWM

Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American International Group's CRBU Position: Q2 2024 in Review

American International Group sold out of Caribou Biosciences (CRBU) in Q2 2024, closing a stake of 40,347 shares — an estimated $207K sold.

American International Group first reported a position in CRBU in Q3 2021 and held it in 11 quarters. The position peaked at $281K in Q3 2022. 140 funds tracked by Wall St. Rank hold CRBU as of Q2 2024.

American International Group reported no remaining Caribou Biosciences position as of Q2 2024 after selling out during the quarter.
American International Group sold 40,347 Caribou Biosciences shares in Q2 2024, an estimated $207K.
American International Group first reported a position in Caribou Biosciences in Q3 2021 and held it in 11 quarters.
American International Group's Caribou Biosciences position peaked at $281K in Q3 2022.
140 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.